-
Quality. For the blood bank, there is nothing more basic than a quality Anti-Human Globulin reagent. Immucor provides an extensive offering of AHG reagents from basic to complex with a choice of package sizes and clear or green reagent dye to improve process controls in your laboratory.
-
Viscoelastic testing with the ROTEM delta and its comprehensive liquid reagent portfolio, provides rapid differential diagnostic information to optimize transfusion decisions in major surgeries and traumatic bleeding scenarios. Coagulation status overview within 10 minutes quickly helps identify underlying coagulopathies and guides appropriate decisions for individualized and goal-directed therapy.
-
Comprehensive. Most Comprehensive Product Line: As the primary supplier for thousands of blood banks across the globe, we offer a complete product line of traditional antisera. From the routine ABO to a monoclonal Anti-P1 and rare lectins, we have the right reagent to fulfill your inventory needs. In the North American market, we offer many reagents that cannot be sourced from any other supplier. Variable Package Sizes: We understand that not all laboratories manage the same workload. To make inventory management more efficient, we provide variable package configurations for many of our routine reagents to support laboratories of all sizes. Made in the USA: All products are manufactured in the USA providing reliable product supply.
-
Increase your productivity by expanding your test menu with Capture-CMV. Designed to improve efficiencies in donor or patient testing, Capture-CMV detects IgG + IgM antibodies to cytomegalovirus in serum or plasma. Capture-CMV is FDA-cleared for patient or donor testing and can be run on the high volume NEO® instrument or the semi-automated Capture workstation.
-
Our Capture-P technology is an innovative IgG platelet antibody detection and crossmatch system. Capture-P assays allow your laboratory to complete specialty platelet compatibility testing with the same methodology utilized for your routine red cell antibody screening. Capture-P® Ready-Screen®: Detects platelet-specific and HLA antibodies. Test wells are coated with platelets from 13 different donors. Capture-P: Utilized for platelet crossmatch assays. Test wells are coated with a specific platelet binding agent.
-
An IgG-specific red cell antibody detection, identification and crossmatch system. Capture-R® Ready-Screen® technology is utilized in the detection of unexpected IgG antibodies to red blood cells by manual, semi-automated or fully automated test methods. Immucor’s broad menu of Capture-R red cell antibody screen and identification assays provides flexibility and standardization in pre-transfusion testing.
-
Capture technology has a proven advantage. Now, more than ever, Immucor offers your laboratory an efficient test method which provides standardized test results with excellent sensitivity and specificity. The semi-automated Capture workstation is designed as a stand-alone solution for small laboratories or as a back-up system to the Echo or NEO. This workstation is easy to use and means antibody screening and identification has never been so efficient.
-
GEM Hemochron 100 whole blood hemostasis system delivers quality results for monitoring and guiding unfractionated heparin therapy during cardiovascular procedures, including cardiac ablation and extracorporeal life support. Leveraging Hemochron technology, the system helps improve workflow and quality of care. Simple cartridge-based technology reduces maintenance and facilities training, for greater efficiency.
-
For rapid whole blood testing, Hemochron Signature Elite system standardizes ACT+, ACT-LR, PT and APTT testing at the point of care. Rapid, accurate and reproducible results, for patient management decisions in acute care settings, from the Cardiovascular Operating Room to the Cardiac Catherization Lab. Rapid Whole Blood Hemostasis testing in acute care settings.
-
The VerifyNow system provides an easy, rapid, and proven solution to assess platelet reactivity to antiplatelet medications, such as Aspirin and clopidogrel. Testing can measure the effect of antiplatelet therapy prior to discharge, ensure patient drug response to generic medications, identify patients at risk for antiplatelet-related bleeding or a major adverse cardiac event, and identify therapeutic non-compliance. This may help reduce time off antiplatelet therapy, length of stay prior to surgery, and 30-day admissions.
Blood Bank
